Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | NAAA | Q02083 | 1/20 | 0.63 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.63 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.63 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.63 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.63 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.63 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11356018 | 0.94 | MEN1 (0.68) | HPGDNAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL10020214 | 0.91 | HPGD (0.79) | HPGDHDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL2614252 | 0.90 | SIGMAR1 (0.68) | NAAANPC1RAB9ATMEM97SIGMAR1 | |
| SCHEMBL2087431 | 0.89 | ALDH1A1 (0.62) | HPGDNAAAHDAC3HDAC4HDAC1 | |
| Hydrochloric Acid SCHEMBL20547794 | 0.88 | ALDH1A1 (0.60) | HPGDNAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL8738694 | 0.87 | MCHR1 (0.66) | HPGDHDAC3SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL18773534 | 0.86 | SMN1; SMN2 (0.60) | HPGDMEN1KMT2ASMN1; SMN2KDM4E | |
| Hydrochloric Acid SCHEMBL4454385 | 0.85 | MCHR1 (0.65) | HPGDHDAC3SMN1; SMN2ALDH1A1SIGMAR1 | |
| SCHEMBL2122336 | 0.85 | HDAC1 (0.58) | HPGDNAAAHDAC3HDAC4HDAC1 | |
| SCHEMBL8411545 | 0.85 | HPGD (0.70) | HPGDHDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4416140-A1 | SULFONYLPIPERAZINYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | F. Hoffmann-La Roche AG (CH) | 2024-08-21 | — | — | EP | claimed |
| CN-117597421-A | Amine enhanced detergents | 雪佛龙奥伦耐有限责任公司 | 2024-02-23 | — | — | CN | claimed |
| US-11884656-B2 | Pyrrole derivatives as PLK1 inhibitors | SENTINEL ONCOLOGY LIMITED (GB) | 2024-01-30 | — | — | US | claimed |
| WO-2023061617-A1 | SULFONYLPIPERAZINYL COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-04-20 | — | — | WO | claimed |
| US-20140141167-A1 | POLYMER TIPS | NEW YORK UNIVERSITY (US) | 2014-05-22 | — | — | US | claimed |
| CN-121824365-A | Amphoteric surfactant and application thereof in IGBT cleaning | 福州大学 | 2026-04-10 | — | — | CN | disclosed |
| US-20250043353-A1 | BIOMARKERS OF RESPONSE TO SELECTIVE INHIBITORS OF AURORA A KINASE | MILLENNIUM PHARM INC (US) | 2025-02-06 | — | — | US | disclosed |
| EP-4352188-A1 | AMINE-BOOSTED DETERGENT | Chevron Oronite Company LLC (US) | 2024-04-17 | — | — | EP | disclosed |
| CN-117597421-A | Amine enhanced detergents | 雪佛龙奥伦耐有限责任公司 | 2024-02-23 | — | — | CN | disclosed |
| WO-2022259193-A1 | AMINE-BOOSTED DETERGENT | CHEVRON ORONITE COMPANY LLC (US) | 2022-12-15 | — | — | WO | disclosed |
| EP-4019255-A1 | DYE INK COMPOSITION, CYAN DYE INK, DYE INK FOR INKJET PRINTING, INKJET PRINTING METHOD, AND DYE AQUEOUS SOLUTION | FUJIFILM Corporation (JP) | 2022-06-29 | — | — | EP | disclosed |
| CN-110023312-A | The Compounds and methods for for preventing malarial parasite from propagating | 由卫生与公众服务部部长代表的美利坚合众国 | 2019-07-16 | — | — | CN | disclosed |
| US-4267102-A | Bleomycin group antibiotics | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1981-05-12 | — | — | US | disclosed |
| US-RE30451-E | ANTITUMOR AGENTS | Zaidan Jojin Biseibutsu Kagaku Kenkyu Kai (JP) | 1980-12-16 | — | — | US | disclosed |
| US-4206144-A | N,N-Dialkyl-N-aminoalkyl-N-(amino or nitro)phenylalkyl- and N-methyl-N-[3-(amino or nitro)phenoxy-2-hydroxy-1-propyl]-N,N-bis(3-aminopropyl)quaternary ammonium salts | STERLING DRUG INC. (US) | 1980-06-03 | — | — | US | disclosed |
| US-4146558-A | Azo dyestuff intermediate nitro- or aminobenzenes ring-substituted by a quaternized amine alkyl or amino-alkoxy group | STERLING DRUG INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4103092-A | Water-soluble quaternary ammonium non-heterocyclic azo dyestuffs | STERLING DRUG INC. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4065500-A | Water-soluble quaternary ammonium azo dyestuffs | STERLING DRUG INC. (US) | 1977-12-27 | — | — | US | disclosed |
| US-3996282-A | Water-soluble quaternary ammonium dyestuffs | STERLING DRUG INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3935182-A | Water-soluble quaternary ammonium heterocyclic azo dyestuffs | STERLING DRUG INC. (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250043353-A1 | BIOMARKERS OF RESPONSE TO SELECTIVE INHIBITORS OF AURORA A KINASE | WNT1, XPOT, CTNNBL1 | HPGD 3671/4885NAAA 4695/4885HDAC3 3981/4885 |
| US-11884656-B2 | Pyrrole derivatives as PLK1 inhibitors | PLK1, CDK1, AURKC | HPGD 2990/4885NAAA 4454/4885HDAC3 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.